Related Experiment Video
Updated: Jul 5, 2025

Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization
Published on: August 11, 2023
[Choroidal neovascularization in central serous chorioretinopathy]
Yu N Yusef1,2, A G Kurguzova1, M V Budzinskaya1
1Krasnov Research Institute of Eye Diseases, Moscow, Russia.
This review covers central serous chorioretinopathy (CSC) with choroidal neovascularization (CNV). It highlights antiangiogenic therapy choices for better patient outcomes.
Area of Science:
- Ophthalmology
- Retinal Diseases
- Vascular Biology
Context:
- Central serous chorioretinopathy (CSC) can lead to choroidal neovascularization (CNV).
- Understanding CSC with CNV is crucial for effective treatment.
- The review focuses on the complexities of managing this condition.
Purpose:
- To review the pathogenesis of CSC-associated CNV.
- To outline differential diagnosis strategies for CSC-CNV.
- To evaluate antiangiogenic therapy options for CSC-CNV.
Summary:
- Discusses CSC pathogenesis and CNV development.
- Details diagnostic approaches for differentiating CSC-CNV.
- Analyzes antiangiogenic drug selection and treatment regimens.
- Emphasizes achieving optimal anatomical and functional results.
Impact:
- Provides insights into managing CSC complicated by CNV.
- Guides clinical decisions on antiangiogenic therapy for CSC-CNV.
- Aims to improve visual outcomes in affected patients.
More Related Videos
10:24Detecting Abnormalities in Choroidal Vasculature in a Mouse Model of Age-related Macular Degeneration by Time-course Indocyanine Green Angiography
Published on: February 19, 2014
09:56In Vivo Multimodal Imaging and Analysis of Mouse Laser-Induced Choroidal Neovascularization Model
Published on: January 21, 2018